Pediatric psoriasis: A descriptive, retrospective and multicenter study in Colombia

Mauricio Torres, Juliana Flórez, María Salomé Páez, Ángela María Londoño, Paola Cárdenas , Mariela Tavera, Mónica Paola Novoa , Carolina Cortés, Rosángela Casanova, .

Keywords: psoriasis, dermatology, prevalence, therapeutics, pediatrics, child, Colombia

Abstract

Introduction. Pediatric psoriasis has a prevalence ranging from 0.5 to 4.1%. It is more common in females, and the predominant type is the vulgar or plaque. It has been associated with comorbidities such as obesity and metabolic syndrome or even with a family history of psoriasis.
Objective. To describe the epidemiological and clinical characteristics of pediatric patients diagnosed with psoriasis attending pediatric dermatology consultations with dermatologists who are members of the Asociación Colombiana de Dermatología from January 2017 to June 2022.
Materials and methods. We conducted a descriptive, retrospective, and multicenter study. We describe the prevalence, clinical characteristics, diagnostic methods, personal and family history, and treatments for patients with pediatric psoriasis. Stata 13™ software was used for data analysis.
Results. From 26,870 patients, 146 were diagnosed with psoriasis (0.54%), with a femaleto-male ratio of 1.5:1 and a median age of onset of eight years. The most common variant was vulgar psoriasis (72.6%), followed by guttate psoriasis (6.85%), and the scalp was the most frequently affected location (55.48%). The most common comorbidities were obesity and Crohn’s disease (5.5% each). Family history included 39 cases of psoriasis, 16 diabetes mellitus, and 7 dyslipidemia. Seventy-eight percent of the cases were classified as mild according to the Psoriasis Area Severity Index (PASI); 65% received topical treatment, and 18% received systemic treatment. Sixty-five percent received topical treatment, while systemic treatment and phototherapy was used in 19% and 2.7%, respectively. When using combined treatment (6%) received topical and systemic modalities, 1.3% used topical with phototherapy, and 0.68% received all treatments.
Conclusion. In the evaluated population, the most frequent variant of pediatric psoriasis was the vulgar type with mild severity. Most patients with this clinical presentation received opical treatment. The association with other systemic diseases implies the need for further studies.

Downloads

Download data is not yet available.

References

1. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ, et al. Prevalence and treatment of psoriasis in the United Kingdom. Arch Dermatol. 2005;141:1537-41. https://doi.org/10.1001/archderm.141.12.1537

2. Eichenfield LF, Paller AS, Tom WL, Sugarman J, Hebert A, Fallon S, et al. Pediatric psoriasis: Evolving perspectives. Pediatr Dermatol. 2018;35:170-81. https://doi.org/10.1111/pde.13382

3. Naldi L, Parazzini F, Gallus S. Prevalence of atopic dermatitis in Italian schoolchildren: Factors affecting its variation. Acta Derm Venereol. 2009;89:122-5. https://doi.org/10.2340/00015555-0591

4. Mahé E. Childhood psoriasis. Eur J Dermatol. 2016;26:537-48. https://doi.org/10.1684/ejd.2016.2932

5. Mercy K, Kwasny M, Cordoro KM, Menter A, Tom WL, Korman N, et al. Clinical manifestations of pediatric psoriasis: Results of a multicenter study in the United States. Pediatr Dermatol. 2013;30:424-8. https://doi.org/10.1111/pde.12072

6. Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis. JAMA. 2020;323:1945-60. https://doi.org/10.1001/jama.2020.4006

7. Osier E, Wang A, Tollefson M, Cordoro K, Daniels S, Eichenfield A, et al. Pediatric psoriasis comorbidity screening guidelines. JAMA Dermatol. 2017;153:698-704. https://doi.org/10.1001/jamadermatol.2017.0499

8. Augustin M, Glaeske G, Radtke M, Christopher E, Reich K, Schäfer I. Epidemiology and comorbidity of psoriasis in children. Brit J Dermatol. 2010;162:633-6. https://doi.org/10.1111/j.1365-2133.2009.09593.x

9. Bronckers IMGJ, Paller AS, van Geel MJ, van de Kerkhof PCM, Seyger MMB. Psoriasis in children and adolescents: Diagnosis, management and comorbidities. Pediatr Drugs. 2015;17:373-84. https://doi.org/10.1007/s40272-015-0137-1

10. Burden-Teh E, Thomas KS, Ratib S, Grindlay D, Adaji E, Murphy R. The epidemiology of childhood psoriasis: A scoping review. Br J Dermatol. 2016;174:1242-57. https://doi.org/10.1111/bjd.14507

11. Kang BY, O’Haver J, Andrews ID. Pediatric psoriasis comorbidities: Screening recommendations for the primary care provider. J Pediatr Health Care. 2021;35:337-50. https://doi.org/10.1016/j.pedhc.2020.12.006

12. Al-Mutairi N, Manchanda Y, Nour-Eldin O. Nail changes in childhood psoriasis: A study from Kuwait. Pediatr Dermatol. 2007;24:7-10. https://doi.org/10.1111/j.1525-1470.2007.00324.x

13. Kumar B, Jain R, Sandhu K, Kaur I, Handa S. Epidemiology of childhood psoriasis: A study of 419 patients from northern India. Int J Dermatol. 2004;43:654-8. https://doi.org/10.1111/j.1365-4632.2004.02182.x

14. Dogra S, Kaur I. Childhood psoriasis. Indian J Dermatol Venereol Leprol. 2010;76:357-65. https://doi.org/10.4103/0378-6323.66580

15. Menter A, Cordoro K, Davis D, Kroshinsky D, Paller A, Armstrong A, et al. Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020;82:161-201. https://doi.org/10.1016/j.jaad.2019.08.049

16. González Ardila CF, Londoño García AM, Cortés Correa CI. Guía de práctica clínica para el tratamiento de la psoriasis en Colombia. Rev Asoc Dermatol. 2018;30(Supl.1):S10-254.

17. Castro Ayarza JR, Franco Franco MD, González Ardila CF, Londoño García ÁM, Hernández Mantilla N. Guía de práctica clínica para el tratamiento de la psoriasis en Colombia: actualización 2022. Rev Asoc Colomb Dermatol Cir Dermatol. 2022;30:231-95.

How to Cite
1.
Torres M, Flórez J, Páez MS, Londoño Ángela M, Cárdenas P, Tavera M, et al. Pediatric psoriasis: A descriptive, retrospective and multicenter study in Colombia. Biomed. [Internet]. 2025 May 30 [cited 2026 Jan. 13];45(2):310-2. Available from: https://revistabiomedicaorg.biteca.online/index.php/biomedica/article/view/7638

Some similar items:

Published
2025-05-30
Section
Original articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo
Escanea para compartir
QR Code